Merck’s investors day had no negative surprises. However, we were given the first glimpses of 2024, which gave us a positive impression. Additionally, the management was confident of meeting the 25by25 target, but was a bit shy about explaining how it believes the existing delta will be organically closed. The breakout sessions provided some helpful insights.